NCT02248051 - Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions

Acute Kidney Injury (Nontraumatic)

Interventions

DRUG

CXA-10

CXA-10 Injectable Emulsion is a sterile emulsion containing CXA-10 in a formulation containing soybean oil, medium chain triglycerides oil, egg phospholipids, sucrose, and disodium EDTA. CXA-10 Injectable Emulsion will be administered intravenously. The active emulsion will be diluted in a vehicle emulsion.

Trial Locations (2)

49007

Jasper Clinical Research & Development, Inc., Kalamazoo

92801

Anaheim Clinical Trials, LLC, Anaheim